Stanley Stern - Net Worth and Insider Trading

Stanley Stern Net Worth

The estimated net worth of Stanley Stern is at least $333,277 dollars as of 2024-05-09. Stanley Stern is the Director of Ormat Technologies Inc and owns about 4,835 shares of Ormat Technologies Inc (ORA) stock worth over $333,277. Details can be seen in Stanley Stern's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stanley Stern has not made any transactions after 2024-03-28 and currently still holds the listed stock(s).

Transaction Summary of Stanley Stern

To

Stanley Stern Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stanley Stern owns 5 companies in total, including Foamix Pharmaceuticals Ltd (FOMX) , Ormat Technologies Inc (ORA) , and Tucows Inc (TCX) among others .

Click here to see the complete history of Stanley Stern’s form 4 insider trades.

Insider Ownership Summary of Stanley Stern

Ticker Comapny Transaction Date Type of Owner
FOMX Foamix Pharmaceuticals Ltd 2020-03-09 director
ORA Ormat Technologies Inc 2024-03-28 director
TCX Tucows Inc 2004-06-02 director
2004-03-12 director & Senior Vice President
2023-05-23 director

Stanley Stern Latest Holdings Summary

Stanley Stern currently owns a total of 1 stock. Stanley Stern owns 4,835 shares of Ormat Technologies Inc (ORA) as of March 28, 2024, with a value of $333,277.

Latest Holdings of Stanley Stern

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORA Ormat Technologies Inc 2024-03-28 4,835 68.93 333,277

Holding Weightings of Stanley Stern


Stanley Stern Form 4 Trading Tracker

According to the SEC Form 4 filings, Stanley Stern has made a total of 4 transactions in Ormat Technologies Inc (ORA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ormat Technologies Inc is the sale of 1,825 shares on March 28, 2024, which brought Stanley Stern around $122,184.

Insider Trading History of Stanley Stern

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stanley Stern Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stanley Stern Ownership Network

Ownership Network List of Stanley Stern

No Data

Ownership Network Relation of Stanley Stern


Stanley Stern Owned Company Details

What does Foamix Pharmaceuticals Ltd do?

Who are the key executives at Foamix Pharmaceuticals Ltd?

Stanley Stern is the director of Foamix Pharmaceuticals Ltd. Other key executives at Foamix Pharmaceuticals Ltd include Chief Scientific Officer Iain Stuart , director & CEO David Domzalski , and CLO and General Counsel Mutya Harsch .

Foamix Pharmaceuticals Ltd (FOMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Foamix Pharmaceuticals Ltd Insider Transactions

No Available Data

Stanley Stern Mailing Address

Above is the net worth, insider trading, and ownership report for Stanley Stern. You might contact Stanley Stern via mailing address: C/o Thcg, Inc, 650 Madison Avenue, 21st Fl, New York Ny 10022.

Discussions on Stanley Stern

No discussions yet.